How does Vera Therapeutics Inc (VERA) change from a tortoise to a hare?

With 0.8 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.77 million shares. The 52-week range on VERA shows that it touched its highest point at $51.61 and its lowest point at $25.99 during that stretch. It currently has a 1-year price target of $65.92. Beta for the stock currently stands at 1.17.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VERA was down-trending over the past week, with a drop of -7.13%, but this was down by -20.11% over a month. Three-month performance dropped to -40.77% while six-month performance fell -30.73%. The stock lost -44.69% in the past year, while it has lost -35.92% so far this year. A look at the trailing 12-month EPS for VERA yields -2.60 with Next year EPS estimates of -3.16. For the next quarter, that number is -0.81. This implies an EPS growth rate of -27.39% for this year and -10.34% for next year. EPS is expected to decline by -10.11% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 10.22%.

Float and Shares Shorts:

At present, 55.03 million VERA shares are outstanding with a float of 48.57 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VERA since 5 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.68769 being high and -$3.03481 being low. For VERA, this leads to a yearly average estimate of -$2.86621. Based on analyst estimates, the high estimate for the next quarter is -$0.81 and the low estimate is -$0.81. The average estimate for the next quarter is thus -$0.81.